Objective
T1D
TYPE 1 DIABETES
Edited by: Chunjiang Wang, Central South University, ChinaReviewed by: Yong Gu, Nanjing Medical University, China; Roque Cardona-Hernandez, Sant Joan de Déu Hospital, SpainIncreasing evidence indicates that the telehealth (TH) model is noninferior to the in-person approach regarding metabolic control in type 1 diabetes (T1D) and offers advantages such as a decrease in travel time and increased accessibility for shorter/frequent visits. The primary aim of this study was to compare the change in glycated hemoglobin (HbA